We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
DELISTED
Sunnova Energy
NOVA
| $965 | ﹤0.01% |
+173
| New | +$822 |
2024 Q2
0 quarters
|
|
2952
Treace Medical Concepts
TMCI
$268M
| $964 | ﹤0.01% |
145
+136
| +1,511% | +$1.1K |
2023 Q4
2 quarters
|
|
2953
DHT Holdings
DHT
$3.78B
| $960 | ﹤0.01% |
83
| – | – |
2023 Q2
4 quarters
|
|
2954
German American Bancorp
GABC
$1.86B
| $954 | ﹤0.01% |
27
-50
| -65% | -$1.63K |
2020 Q3
15 quarters
|
|
2955
Dyne Therapeutics
DYN
$2.86B
| $953 | ﹤0.01% |
+27
| New | +$785 |
2024 Q2
0 quarters
|
|
2956
Metallus
MTUS
$846M
| $953 | ﹤0.01% |
+47
| New | +$1.03K |
2024 Q2
0 quarters
|
|
2957
MarineMax
HZO
$1.16B
| $939 | ﹤0.01% |
+29
| New | +$850 |
2024 Q2
0 quarters
|
|
2958
Onterris Inc
ONT
$494M
| $936 | ﹤0.01% |
+21
| New | +$945 |
2024 Q2
0 quarters
|
|
2959
Protagonist Therapeutics
PTGX
$8.84B
| $936 | ﹤0.01% |
+27
| New | +$791 |
2024 Q2
0 quarters
|
|
2960
Oruka Therapeutics
ORKA
$4.89B
| $935 | ﹤0.01% |
20
| – | – |
2021 Q3
11 quarters
|
|
2961
Openlane
OPLN
$4.51B
| $929 | ﹤0.01% |
56
| – | – |
2017 Q1
29 quarters
|
|
2962
NextDecade
NEXT
$1.6B
| $929 | ﹤0.01% |
117
| – | – |
2022 Q4
6 quarters
|
|
2963
Cohu
COHU
$2.6B
| $927 | ﹤0.01% |
+28
| New | +$869 |
2024 Q2
0 quarters
|
|
2964
Tronox
TROX
$565M
| $926 | ﹤0.01% |
+59
| New | +$1.07K |
2024 Q2
0 quarters
|
|
2965
PTC Therapeutics
PTCT
$5.09B
| $917 | ﹤0.01% |
+30
| New | +$972 |
2024 Q2
0 quarters
|
|
2966
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.9B
| $915 | ﹤0.01% |
20
| – | – |
2017 Q2
28 quarters
|
|
2967
BridgeBio Pharma
BBIO
$13.1B
| $912 | ﹤0.01% |
+36
| New | +$984 |
2024 Q2
0 quarters
|
|
2968
STAAR Surgical
STAA
$1.12B
| $905 | ﹤0.01% |
+19
| New | +$833 |
2024 Q2
0 quarters
|
|
2969
Keel Infrastructure Corp
KEEL
$1.59B
| $900 | ﹤0.01% |
350
| – | – |
2023 Q4
2 quarters
|
|
2970
nLIGHT
LASR
$2.05B
| $896 | ﹤0.01% |
+82
| New | +$997 |
2024 Q2
0 quarters
|
|
2971
MINISO
MNSO
$3.09B
| $896 | ﹤0.01% |
47
-44
| -48% | -$970 |
2023 Q2
4 quarters
|
|
2972
TaskUs
TASK
$781M
| $892 | ﹤0.01% |
67
| – | – |
2022 Q4
6 quarters
|
|
2973
Bankunited
BKU
$2.99B
| $884 | ﹤0.01% |
30
| – | – |
2016 Q4
30 quarters
|
|
2974
Lifestance Health
LFST
$4.7B
| $884 | ﹤0.01% |
180
+64
| +55% | +$386 |
2022 Q4
6 quarters
|
|
2975
Acadia Realty Trust
AKR
$2.54B
| $878 | ﹤0.01% |
49
+32
| +188% | +$546 |
2024 Q1
1 quarter
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.